Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  imiquimod
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 35 for your search:
Start Over
Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 0559/07, NCT00803907
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Phase: Phase IV
Type: Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10-0933, NCT01229319
Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: IPDTAKOTR/V06/28.12.11, NCT01538901
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Phase: Phase IV
Type: Diagnostic, Health services research, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 23592103, NCT01663558
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0041-63, 2012-003112-31, NCT01926496
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Phase: Phase IV
Type: Health services research, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL50621.068.14, 836031011, 2014-003691-23, NCT02281682
Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Trial Photoderm Graz 2010-1, NCT01088737
Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: CIP#NMCSD.2014.0040, NCT02130323
Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ITIC2, NCT01283763
Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD11/06-S, NCT01720407
Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: KLI293, NCT01861535
Imiquimod, Fluorouracil, or Observation in Treating Patients With High-Grade Anal Squamous Skin Lesions Who Are HIV-Positive
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 27 and over
Sponsor: NCI, Other
Protocol IDs: AMC-088, NCI-2013-02288, U01CA121947, NCT02059499
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 35 and over
Sponsor: NCI, Other
Protocol IDs: AMC-A01, NCI-2014-00636, U01CA121947, NCT02135419
Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
Phase: Phase III
Type: Health services research, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL50433.068.14, NCT02242929
Imiquimod Treatment of CIN Lesions
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: METC 13-2-031, NCT02329171
Topical 5% Imiquimod Cream for Vulvar Paget's Disease
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NL51648.091.14, NCT02385188
Radiotherapy or Imiquimod in Complex Lentigo Maligna
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: ANZMTG 02.12, NCT02394132
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Luc 10-002, NCT01191034
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NYU 11-00598, 1R01CA161891-01, NCT01421017
Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment
Phase: Phase II
Type: Prevention
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: _1.0, ISRCTN: 2008-004893-42, NCT00941811
Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MM1120, NCT01543464
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UbiVac DPV-001, R44CA121612, NCT01909752
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: Pro00000581, P50CA108786, P30CA014236, SPORE Project 3, CDR0000579683, DUMC-PRO00000581, NCT00626483
Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
Phase: Phase I
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Other
Protocol IDs: 2009LS136, 1004M81213, NCT01400672
Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 100
Sponsor: Other
Protocol IDs: 20110462, NCT01803152
Start Over